⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11098092 | 0.76 | — | — | |
| SCHEMBL2021636 | 0.72 | — | — | |
| SCHEMBL11203623 | 0.70 | — | — | |
| SCHEMBL912621 | 0.68 | — | — | |
| SCHEMBL34460541 | 0.68 | — | — | |
| SCHEMBL1931721 | 0.67 | APLNR (0.35) | — | |
| SCHEMBL490967 | 0.67 | — | — | |
| SCHEMBL2816024 | 0.67 | — | — | |
| SCHEMBL2903929 | 0.67 | — | — | |
| SCHEMBL60402 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096782-A1 | FLUORINATED CANNABINOID COMPOSITIONS AND METHODS THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2025-05-08 | — | — | WO | claimed |
| WO-1992020673-A1 | ANTIHYPOTENSIVE BENZOFURAN DERIVATIVES WITH N-LINKED 1H-IMIDAZOLYLMETHYL-5-CARBOXAMIDE SUBSTITUENTS | GLAXO GROUP LIMITED (GB) | 1992-11-26 | — | — | WO | claimed |
| WO-1992020674-A1 | 1H-IMIDAZOL-1-YL-METHYL BENZOFURAN DERIVATIVES, WITH THE IMIDAZOLYL MOIETY BEING SUBSTITUTED BY A CYCLOALKYL GROUP | GLAXO GROUP LIMITED (GB) | 1992-11-26 | — | — | WO | claimed |
| US-20260146047-A1 | MACROCYCLIC HETEROCYCLE COMPOUNDS AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-05-28 | — | — | US | disclosed |
| EP-4199925-B1 | CYCLOPENTAPYRROLE OREXIN RECEPTOR AGONISTS | MERCK SHARP & DOHME LLC (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20260124201-A1 | CYCLOPENTANE COMPOUND | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2026-05-07 | — | — | US | disclosed |
| US-20260109711-A1 | MACROCYCLIC SULFONAMIDE MODULATORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4720076-A1 | SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS | H. Lundbeck A/S (DK) | 2026-04-08 | — | — | EP | disclosed |
| US-20260092053-A1 | KHK INHIBITORS | GILEAD SCIENCES INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4680611-A1 | MACROCYCLIC HETEROCYCLE COMPOUNDS AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2026-01-21 | — | — | EP | disclosed |
| EP-4681774-A2 | KHK INHIBITORS | Gilead Sciences, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-1996028090-A1 | A METHOD OF MAGNETIC RESONANCE FOCUSED SURGICAL AND THERAPEUTIC ULTRASOUND | IMARX PHARMACEUTICAL CORP. (US) | 1996-09-19 | — | — | WO | disclosed |
| EP-0672041-A1 | PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | Novartis AG (CH) | 1995-09-20 | — | — | EP | disclosed |
| WO-1995009853-A1 | PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF | CIBA-GEIGY AG (CH) | 1995-04-13 | — | — | WO | disclosed |
| WO-1993005025-A1 | C-LINKED PYRAZOLE DERIVATIVES | GLAXO GROUP LIMITED (GB) | 1993-03-18 | — | — | WO | disclosed |
| EP-0526976-A1 | Perfluoroalkyl halides and derivatives | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-02-10 | — | — | EP | disclosed |
| EP-0430579-A2 | Fluoroaliphatic-group-substituted esters and method of making the same | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-06-05 | — | — | EP | disclosed |
| EP-0042750-A2 | Quinoxalinyloxy ethers as selective weed control agents | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-12-30 | — | — | EP | disclosed |
| US-4056622-A | MICROBIOCIDES, FUNGICIDES, BACTERICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-11-01 | — | — | US | disclosed |
| US-RE29032-E | ANTIINFLAMMATORY AGENTS | RIKER LABORATORIES, INC. (US) | 1976-11-09 | — | — | US | disclosed |